KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to -0.33%.

  • Moderna's Return on Capital Employed fell 13.00% to -0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.33%, marking a year-over-year decrease of 13.00%. This contributed to the annual value of -0.28% for FY2024, which is 6.00% down from last year.
  • As of Q3 2025, Moderna's Return on Capital Employed stood at -0.33%, which was down 9.81% from -0.30% recorded in Q2 2025.
  • In the past 5 years, Moderna's Return on Capital Employed ranged from a high of 0.97% in Q4 2021 and a low of -0.34% during Q1 2024.
  • For the 3-year period, Moderna's Return on Capital Employed averaged around -0.21%, with its median value being -0.30% (2025).
  • In the last 5 years, Moderna's Return on Capital Employed skyrocketed by 145bps in 2021 and then slumped by 85bps in 2023.
  • Over the past 5 years, Moderna's Return on Capital Employed (Quarterly) stood at 0.97% in 2021, then slumped by 52bps to 0.45% in 2022, then tumbled by 71bps to -0.27% in 2023, then dropped by 4bps to -0.31% in 2024, then declined by 13bps to -0.33% in 2025.
  • Its Return on Capital Employed was -0.33% in Q3 2025, compared to -0.30% in Q2 2025 and -0.32% in Q1 2025.